Laura brings more than a decade of health policy experience. Her portfolio includes the U.S. drug supply chain (insurers, pharmacy benefit managers and manufacturers), Medicare Parts B and D, Medicaid, and general health policy. 

Prior to joining AAF, Laura held policy roles with two large pharmacy benefit managers (PBMs) as well with the Pharmaceutical Care Management Association. Laura also led several health policy focused projects for private equity firms at Capstone, a policy and regulatory due diligence firm. Early in her career, she served in three professional offices in the House of Representatives.   

Laura holds an MA in the History of Medicine from the University College London and a BA in History from American University.